|
Crd (b)(4) device registry, patient site id: us0202 - 3851 (b)(6).It was reported that on (b)(6) 2026, a 25mm epic max aortic valve was chosen for implant.During procedure, patient became hypotensive.Post-procedure, patient experienced bleeding from aortic patch and subsequently received blood product transfusions and protamine.Medication was also administered to treat continued hypotension.It was then reported on (b)(6) 2026, patient complained of increased chest pain.Electrocardiogram reported new onset atrial fibrillation, though patient remained hemodynamically stable.Medication, amiodarone, was administered and patient converted back to normal sinus rhythm.The patient's post-operative course included intermittent in and out atrial fibrillation and a self-limited run of ventricular tachycardia on (b)(6) 2026.Medication was adjusted and metoprolol was increased and replete electrolytes.Patient was discharged home in normal sinus rhythm.
|